Northern Light Venture Capital

VOC AI offers AI tools for ecommerce insights and customer service solutions.

AscentStream is a technology company specializing in cloud messaging software and stream processing solutions. It caters specifically to the Chinese market, offering financial-grade products and services built on Apache Pulsar. The company's offerings enable enterprises to modernize their systems and facilitate seamless cloud adoption by transforming distributed core systems.

Shengrun New Materials is an aerogel material and system solution service provider integrating advanced material process research and development, product application development, advanced production line design, and mature system solutions.

Weshare is an IT company that specializes in big data, cloud computing, and artificial intelligence services. Weshare pursue the innovative and harmonious development of people, things, and the business ecosystem which creates maximum value with the trend. They are committed to providing scientific and technological services worldwide through continuous exploration and technologies.

TULIU.com is an online platform dedicated to facilitating land transfers in China. It aggregates essential information such as land area, pricing, and development trends to create a standardized evaluation system. The company offers farmers complimentary land value assessment services, helping them understand the worth of their properties. In addition to its evaluation services, TULIU.com provides comprehensive information about real estate, including details on available properties for sale or lease, insights into land brokers, land indexes, and updates on relevant laws and policies governing land transfer and leasing. This holistic approach enables users to make informed decisions regarding their real estate needs.

RootData is a technology company that specializes in providing a comprehensive data platform for Web3 assets. It aggregates and organizes both on-chain and off-chain data, offering investors and entrepreneurs a systematic database to explore and evaluate crypto projects. The platform delivers news, project information, and refined screening tools based on blockchains and tags, helping investors make informed decisions.

Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.

Coordinate System Intelligence is a provider of automotive brake-by-wire system solutions. It focuses on providing core technology solutions.

Infinigence is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.

Sanegene Bio is a biotechnology company focused on developing RNA interference (RNAi) therapeutics aimed at addressing unmet clinical needs across various therapeutic areas. Its innovative RNAi drug discovery platform targets disease-causing genes, effectively knocking them down to provide potential treatments for conditions such as cardiovascular and metabolic diseases, immunology-related disorders, and diseases affecting the nervous system. By leveraging advanced RNA technology, Sanegene Bio is capable of achieving specific delivery of multiple RNA drugs, enhancing the effectiveness of its therapeutic offerings for patients suffering from a range of health issues, including infectious diseases and eye conditions.

Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.

Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.

Chaoying Pharmaceutical offers ultrasonic contrast agent preparation technologies along with the installation of sterile production lines which can be used for real-time monitoring and evaluation of various surgeries.

Kangpu Biopharmaceuticals is a clinical-stage company dedicated to developing innovative small molecule drugs targeting immuno-modulating sites for treating cancer, autoimmune diseases, and inflammation. The company's proprietary technologies enable it to generate and degrade ubiquitin-protein, while its X-Synergy® drug discovery platform facilitates the development of novel therapies. Kangpu aims to improve patients' health conditions efficiently through its targeted protein ubiquitination and degradation solutions.

Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.

Aegis is a blockchain security company.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

Quick Sensing is a high-pressure-pressure automotive sensor developer.

ECTEK is a developer and manufacturer specializing in electronic control hardware and software platforms. The company provides a customized and open electronic control platform designed to facilitate the integration of various power systems. Its product offerings include electronically controlled systems for diesel engines, gas engines, and pure electric power, as well as solutions for automated manual transmission (AMT), oil-electric hybrid systems, and fuel cells. Additionally, ECTEK focuses on intelligent network connections and related service systems, enabling customers to achieve seamless integration across their power systems.

Xinrui Medical is a domestic enterprise that engages in the research and development of polymer valves. It focuses on new polymer valves to build a complete solution for heart valve disease. The team members have long been engaged in the research and development of polymer synthesis and polymer-related medical devices. They are all from well-known medical device companies and have complete product development experience and mature industrialization thinking.

Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

Yizhi Electronic Technology Co., Ltd. is a technology company specializing in system solutions centered around AI machine vision algorithms and SOC chip design. Established in Zhuhai in 2016, it has expanded its presence with offices in Beijing and Shenzhen. Yizhi employs over 100 professionals, primarily graduates from top domestic universities, and its core team has extensive experience in successful SOC chip mass production. The company emphasizes independent research and development of intellectual property, focusing on areas such as AI acceleration, high-definition display, and audiovisual codec technologies. Yizhi's offerings cater to various sectors, including intelligent security, automotive electronics, and smart home applications, enabling clients to effectively manage comprehensive system construction, hardware development, and market outreach.

Surpath is an AI-driven cloud-based platform that formulates optimal supply chain solutions based on clients' needs. The firm provides cross-border transportation to destination services, optimized logistics, and analytics solutions that solve complex problems.

HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.

Point One is a 3D Metaverse user-generated content platform. Using simple no-code tools, users may build personalized 3D interactive content.

BUD, founded in 2019 by former Snap engineers Risa Feng and Shawn Lin, is a Singapore-based company developing a user-generated open metaverse gaming platform. The platform connects millions of virtual worlds created by a community of approximately 9 million creators. Since its global launch in November 2021, BUD has rapidly gained popularity, ranking among the top 10 social apps in over 38 countries, including regions such as North America and Southeast Asia. The platform enables users to create and share 3D interactive experiences without requiring technical expertise, allowing for easy customization through a drag-and-drop interface. Users can explore a variety of experiences, from social hangout spaces to battle royale games, positioning BUD as a vibrant digital social hub where millions come to create, play, and interact.

Jingwei Shida is a medical equipment R&D and supplier, focusing on the research and development of optoelectronic medical equipment.

CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

"Huahuixin" was established in 2017. Its core capabilities are the design, development and production of micro-nano structured optical chips and laser chips, which are in the upstream chip manufacturing link of the optoelectronics industry. There are two main business models: on the one hand, relying on high-end optoelectronic chip technology capabilities to provide joint R&D and foundry services for optoelectronic chip design companies; on the other hand, based on the team's technical capabilities in micro-nano structured optical chips and laser chips, Independent research and development, design and large-scale production of optoelectronic products.

Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.

Xinrui Medical is a domestic enterprise that engages in the research and development of polymer valves. It focuses on new polymer valves to build a complete solution for heart valve disease. The team members have long been engaged in the research and development of polymer synthesis and polymer-related medical devices. They are all from well-known medical device companies and have complete product development experience and mature industrialization thinking.

Xmov Ai is a company that specializes in developing artificial reality animation solutions tailored for enterprise users across various Metaverse business scenarios. By leveraging advanced motion capture, animation, and artificial intelligence technologies, Xmov Ai provides businesses with customized interactive solutions for their virtual environments. The company offers a comprehensive infrastructure for 3D virtual content production, focusing on creating, educating, and employing individuals within the virtual realm. With a strong R&D team and proprietary computer graphics capabilities, Xmov Ai has established a diverse array of applications in several sectors, including entertainment, cultural tourism, e-commerce, finance, education, and healthcare. This multi-faceted approach allows Xmov Ai to create a robust ecosystem designed to support the evolving needs of the virtual world.

Binance.US operates as a regulated cryptocurrency exchange that offers a marketplace for buying, selling, and trading a variety of digital assets. It is recognized as a FinCEN regulated entity in the United States, ensuring compliance with relevant financial regulations. The platform is designed to promote financial confidence and enhance crypto literacy among users, providing access to innovative technology that facilitates trading with low fees and transaction costs. Binance.US aims to support the transition to a digital economy by delivering a fast, secure, and reliable trading environment for everyday users.

Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base, specializes in high-speed and high-precision radiology imaging solutions. With a significant research and development presence in Yonyou Industrial Park and a subsidiary in Chengdu, the company focuses on static computed tomography (CT), X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision developed China's first self-designed CMOS flat panel detector, known as the Merak series, which serves a diverse range of applications across medical, industrial, and security sectors. By providing advanced technological support both domestically and internationally, Nanovision aims to enhance imaging capabilities in various fields.

Tensor Security is a full-stack endogenous cloud-native security solution. Their solution includes automation and devsecops,safety compliance, market container security,dynamic privileged account management, and cloud host security. Their cloud-native security platform builds a trusted image security system to ensure image security throughout the entire life cycle of cloud-native applications.

Nutshell Therapeuticstein drug discovery platform, composed of a well-integrated set of computational modules and experimental tools based on a proprietary AI algorithm and deep know-how derived from biochemistry and biophysics, possesses the capability to discover a host of drug entities, including various types of protein activators and subtype/mutation-selective small molecules.

Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China.

HemaCell is a biotechnology company specializing in cell therapy, specifically focused on regenerating hematopoietic lineages, which include blood and immune cells, through advanced in vitro techniques. Leveraging innovative stem cell reprogramming, editing, and differentiation technologies, HemaCell aims to address the critical shortage of platelets necessary for treating various diseases such as cancer, liver disease, critical illness, and hematological disorders. The company employs a unique platform that utilizes platelets as drug delivery carriers, facilitating the rapid establishment of induced pluripotent stem cells (iPSCs) and gene targeting technologies. In addition to platelet production, HemaCell is dedicated to developing novel therapeutic solutions for diseases associated with platelet abnormalities, thereby offering effective treatment options and addressing significant medical needs.

Ucello Therapeutics focuses on the development of allogeneic cell therapies utilizing its proprietary CAR-T cell technology platform, known as CBT-X20. The company aims to create universal CAR-T cell therapeutic drugs that address unmet clinical needs in cancer treatment. By leveraging advanced gene and cell therapy technologies, Ucello's therapies target cancer cells at the molecular level, making them accessible to patients with varying lymphocyte levels and those with a history of transplant relapse. This innovative approach allows for effective cancer gene therapies to be administered to individuals with specific pre-existing medical conditions.

Genepoint Biological Technology, based in Shanghai, China, specializes in manufacturing and distributing advanced devices for cryogenic biomaterial storage and handling. Their product portfolio includes automated cryo-bio storage systems, hybrid cryo-storage solutions, LIN vapor freezers, and specialized hoists for freezers, catering to life sciences researchers. The company is committed to advancing IoT, automation, and intelligence technologies in the field of cryogenic biomaterial management.

Mindfront Health is a mental health company based in Shanghai, China, specializing in comprehensive diagnosis, treatment, and evidence-based psychotherapy services. Founded in 2020, it operates as a brand under Luye Life Sciences Group and focuses on addressing various mental health issues, including depression, sleep disorders, ADHD, and gaming addiction. Mindfront Health utilizes a combination of evidence-based drug treatments and non-drug interventions to create personalized treatment plans tailored to the needs of the Chinese population. The company has established six facilities in major cities such as Shanghai, Shenzhen, Guangzhou, and Xi'an, in addition to offering an internet medical service platform. Through strategic collaborations with domestic institutions and leveraging Luye's clinical service and operational expertise from Australia, Mindfront Health aims to replicate its model at scale, providing holistic solutions for mental health care.

OUTPUT is a creative platform for the innovation of digital experiences. It features cutting-edge digital artists, designers, and developers across the globe, initiating cross-industrial practices online and offline, updating multi-dimensional experiences generated by digital art and design, and nurturing a central hub for generative dialogues via digital experiences.

H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.

CATUG Biotechnology specializes in the development and application of innovative biomedical technologies, particularly in the realm of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services that span the entire industry chain, from research and development to clinical applications and industrialization. With research and development centers and industrialization bases situated in Suzhou and Wuhan, CATUG is well-equipped to support the drug research and production needs of its clients.

Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.

Stellar Cyber Inc. is a cybersecurity company that develops an open Extended Detection and Response (XDR) platform aimed at enhancing application and data protection for organizations. Founded in 2015 and based in Santa Clara, California, the company focuses on providing comprehensive threat detection and response technology. Its platform ingests data from various security tools, automatically detecting and correlating alerts into incidents across the entire attack surface. This capability enables organizations to identify and remediate attack activities early and accurately, thereby significantly reducing enterprise risk. Additionally, Stellar Cyber's solutions facilitate effortless deployment of sensors in both on-premise and cloud environments, optimize analyst productivity, and enhance existing security investments while minimizing costs. The company was previously known as Aella Data Inc. before rebranding in February 2019.

Novlead Biotech is a company dedicated to enhancing human health through innovative medical technologies. It specializes in the development and manufacturing of medical devices that target cardiopulmonary, respiratory, and anti-infection applications. The company's primary focus is on the medical use of nitric oxide to address conditions such as pulmonary hypertension and infectious diseases. By leveraging its technological advancements, Novlead Biotech aims to improve treatment efficiency in hospitals and enhance the quality of life for patients.

TenaFe, Inc. is a technology company based in Campbell, California, that specializes in the development of solid-state drive (SSD) controllers. Founded in 2018, TenaFe focuses on creating innovative solutions for data storage challenges across various applications, including client devices, data centers, and emerging edge technologies. The company's patented technology aims to enhance the reliability, performance, and energy efficiency of SSDs, catering to a diverse range of devices from personal computers to connected gadgets. By leveraging its advanced controller technology, TenaFe seeks to provide clients with improved storage solutions that meet the evolving demands of modern data management.

RiVAI Technologies is a prominent developer of high-performance RISC-V based CPUs and customized system-on-chip (SoC) designs. The company specializes in creating advanced artificial intelligence chips tailored for Internet of Things (IoT) applications, serving a diverse range of sectors such as wearable technology, smart home devices, security systems, agriculture, and consumer electronics. By leveraging RISC-V, an open standard instruction set architecture, RiVAI enables its clients to achieve low-power and high-performance processing capabilities essential for modern computing demands, from edge devices to data centers.

It provides mobile enterprise resource planning(ERP) systems for sales, production and storage management.

HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

New Nuclear Cloud is an industrially intelligent software service company that combines data and processes to realize the needs of manufacturing enterprises and configure services. They provide container technologies and services to meet the various needs of enterprises for data deployment.

Bombax is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Bombax allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

Orient Speech Therapy Center specializes in providing professional speech and language therapy services for children facing communication challenges, including those with autism or speech disorders. The center focuses on the early screening, clinical diagnosis, and therapeutic interventions essential for improving children's speech and social skills. It offers a range of refined curricula designed specifically for young learners, including the Star Curriculum, phonics and oral muscle courses, expression courses, and exercise classes. Through these structured programs, Orient Speech Therapy Center aims to enhance the communicative abilities of children, enabling them to express themselves more effectively and engage socially.

Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

Nutshell Therapeuticstein drug discovery platform, composed of a well-integrated set of computational modules and experimental tools based on a proprietary AI algorithm and deep know-how derived from biochemistry and biophysics, possesses the capability to discover a host of drug entities, including various types of protein activators and subtype/mutation-selective small molecules.

OmniSensing Photonics specializes in the development and manufacturing of advanced photonic sensing solutions and high-end LiDAR technology. Its product range includes the DFS-2 series dual fiber sensor pluggable module, the POF-48 series fiber cable extended multi-channel optical sensing probe, and the MV-H series compact laser vibrometer sensor, all designed for precise vibration and displacement measurements. These solutions cater to a variety of scientific and industrial applications, particularly in emerging fields such as precision manufacturing, machine vision, and autonomous driving. By leveraging photonics chips and all-in-one packaging technologies, OmniSensing aims to offer innovative and customer-focused sensing products that challenge traditional industrial practices.

Speedaf Logistics Limited specializes in integrated logistics and transportation services primarily between China and Africa. Founded in 2019 and headquartered in Shenzhen, China, the company offers a comprehensive range of services, including air, sea, and road transportation, as well as warehousing, packaging, and labeling. Speedaf aims to optimize logistics costs and enhance efficiency through its platform, which provides order information and online tracking services. With additional offices in Ghana, Nigeria, Kenya, and Uganda, Speedaf positions itself as a one-stop logistics service provider, delivering stable and recognized supply chain solutions to its clients in the region.

LuxCreo Inc., founded in 2017, is a leader in dental innovation, offering a comprehensive additive manufacturing platform that has received FDA Class II 510(k) clearance. The company specializes in 3D printed dental solutions, significantly enhancing productivity in dental clinics and laboratories by 3 to 10 times. LuxCreo enables the same-day production of dental appliances such as aligners, retainers, night guards, and splints, thus improving patient care through increased precision and speed. In addition to its core dental offerings, LuxCreo is also engaged in software and electronic hardware development, alongside material innovation, to advance 3D printing technology. This holistic approach not only streamlines manufacturing processes but also contributes to cost reduction for its clients.

Yuanbao provides users with insurance products and services. The company's product types include medical insurance, critical illness insurance, and comprehensive accident insurance. The company are committed to providing customers with domestic insurance planning services and helping customers customize insurance plans.

Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

InnoStar Semiconductor is a developer and provider of advanced semiconductor storage technology, specializing in resistive random access memory (ReRam) chips. The company focuses on creating high-performance, low-power storage solutions tailored for applications in information security, Internet of Things (IoT), artificial intelligence (AI), and cloud computing. By commercializing its innovative ReRam technology, InnoStar aims to redefine storage capabilities and intelligent computing, enabling businesses to enhance security measures and meet the growing demands for efficient data storage and processing. Through its commitment to technological advancement, InnoStar Semiconductor is poised to set industry benchmarks in the semiconductor sector.

Brattea is a medical device research and development company specializing in renal denervation products aimed at addressing various health conditions, including hypertension, cancer pain, and diabetes. The company develops interventional devices that include renal artery ablation catheters, radiofrequency ablation equipment, and medical mapping systems. These products are designed to treat a range of medical issues, such as refractory hypertension, obstructive sleep apnea, kidney disease, and heart failure. Through its innovative approach, Brattea aims to provide reliable solutions that improve patient outcomes and enhance the quality of care in the medical field.

Immune-Onc Therapeutics, Inc. is a biopharmaceutical company based in Palo Alto, California, founded in 2016. The company specializes in the discovery and development of innovative biologic treatments, particularly aiming to create therapeutic antibodies for cancer. Immune-Onc Therapeutics leverages scientific insights related to the tumor microenvironment and immune suppressive pathways to develop first-in-class biotherapeutics. By targeting myeloid cells, it aims to disarm immune suppression within tumors, facilitating new immunomodulatory approaches for cancer treatment. The company's focus on advancing novel immuno-oncology products positions it to provide effective new treatment options for cancer patients.

Vivest engages in R&D of emergency medical equipment.

MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

Minayo is a food company that specializes in the manufacture and distribution of health supplements and functional snacks. It is dedicated to producing products that enhance consumer health and performance, offering a range of convenient options that cater to the growing demand for nutritious and functional food alternatives. By focusing on quality and innovation, Minayo aims to support individuals in achieving their health goals through effective dietary solutions.

Teon Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood, California, focused on advancing cancer immunotherapy. Founded in 2018, the company specializes in the discovery and development of small molecule drugs aimed at inhibiting immunosuppressive and cancer-promoting signaling pathways within the tumor microenvironment. Teon Therapeutics is dedicated to improving the lives of cancer patients by developing a targeted portfolio of molecules that not only restore antitumor immunity but also suppress cancer cell proliferation. Their lead program involves an A2BR-specific antagonist that is set to enter Phase 1b clinical trials. By integrating metabolic checkpoint inhibitors and GPCR immune checkpoint inhibitors, Teon aims to enhance the efficacy of existing immunotherapies and improve long-term outcomes for cancer patients.

Singular Medical is a technology company focused on the research and development of cardiac rhythm management (CRM) products. It specializes in designing and industrializing a comprehensive range of high-quality medical devices, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. By creating a complete technical platform, Singular Medical offers solutions that encompass the entire patient journey, from initial detection of cardiac issues to ongoing follow-up care. The company's commitment to providing reliable and professional medical equipment aims to enhance the quality of care for patients with various cardiac conditions.

Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Orient Speech Therapy Center specializes in providing professional speech and language therapy services for children facing communication challenges, including those with autism or speech disorders. The center focuses on the early screening, clinical diagnosis, and therapeutic interventions essential for improving children's speech and social skills. It offers a range of refined curricula designed specifically for young learners, including the Star Curriculum, phonics and oral muscle courses, expression courses, and exercise classes. Through these structured programs, Orient Speech Therapy Center aims to enhance the communicative abilities of children, enabling them to express themselves more effectively and engage socially.

New Nuclear Cloud is an industrially intelligent software service company that combines data and processes to realize the needs of manufacturing enterprises and configure services. They provide container technologies and services to meet the various needs of enterprises for data deployment.

magAssist, founded in 2017 by Dr. Xu Bozhen, is a high-tech enterprise based in Suzhou, specializing in the development of in-vitro artificial heart devices aimed at assisting patients with cardiovascular diseases. The company focuses on creating short-term to medium-term ventricular assist devices that are compatible with various blood types. Utilizing advanced fluid mechanics and magnetic suspension technology, magAssist aims to minimize incompatibility issues in patients, thereby enhancing their recovery and treatment processes. The core team consists of leading experts in artificial heart engineering, leveraging extensive experience in research and development to produce domestically manufactured devices with independent intellectual property rights.

Picky is a mobile-first community dedicated to helping consumers discover the most suitable skincare and beauty products through user reviews, educational content, and expert contributions. The platform emphasizes authenticity, education, and personalization, allowing users to engage with content focused on skincare, including K-beauty. Picky offers a Skin Type Analyzer, a quick tool that helps users identify their skin type through a series of 14 simple questions. Based on the results, users can better understand their unique skin characteristics and find products tailored to their needs. The platform boasts a regularly updated database of over 40,000 beauty products, ranging from established favorites to emerging indie K-beauty brands. Additionally, Picky connects users with healthcare professionals, facilitating appointments with optometrists, dermatologists, dentists, and plastic surgeons, streamlining access to health and beauty services.

GenFleet Therapeutics, established in 2017 and headquartered in Shanghai, China, is a biotechnology company focused on cancer research and development. It specializes in creating therapeutic molecules, including signal transduction regulators, tumor microenvironment modulators, and transcription factors, to target various cancer systems. The company aims to develop innovative molecular-level pharmaceuticals and antibody drugs that can effectively stimulate the body's immune response against tumors. GenFleet serves both domestic and international clients.

VesiCURE Therapeutics is a biotechnology company based in Suzhou, Jiangsu, China, founded in 2021. It specializes in the research and development of innovative drugs utilizing exosomes, also known as extracellular vesicles. The company is dedicated to advancing the understanding and application of exosomal drugs, contributing to the growth and enhancement of the exosomal pharmaceutical industry. Through its research initiatives, VesiCURE aims to promote the development of effective therapies that harness the unique properties of exosomes for medical applications.

Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

Novlead Biotech is a company dedicated to enhancing human health through innovative medical technologies. It specializes in the development and manufacturing of medical devices that target cardiopulmonary, respiratory, and anti-infection applications. The company's primary focus is on the medical use of nitric oxide to address conditions such as pulmonary hypertension and infectious diseases. By leveraging its technological advancements, Novlead Biotech aims to improve treatment efficiency in hospitals and enhance the quality of life for patients.

Applied Cells is a biotechnology company founded in 2017 and based in Santa Clara, California, specializing in innovative solutions for cell separation and enrichment. The company focuses on developing tools that isolate rare cancer cells and extract high-quality immune cells, enhancing outcomes in cell therapy. By integrating advanced immuno-separation, active-microfluidics, and fluidics control technologies, Applied Cells aims to transform cellular sample preparation processes. Its products are designed to enable medical professionals and researchers to efficiently prepare samples, thereby advancing cancer diagnosis and treatment.

Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&D transformation center, GMP production base, and medical testing laboratory in Beijing.

Genepoint Biological Technology, based in Shanghai, China, specializes in manufacturing and distributing advanced devices for cryogenic biomaterial storage and handling. Their product portfolio includes automated cryo-bio storage systems, hybrid cryo-storage solutions, LIN vapor freezers, and specialized hoists for freezers, catering to life sciences researchers. The company is committed to advancing IoT, automation, and intelligence technologies in the field of cryogenic biomaterial management.

JAKA Biotech is a manufacturer based in MinHang District, Shanghai, China, specializing in cosmetic functional raw materials. Founded in 2010, the company is dedicated to delivering effective skincare solutions through its expertise in plant extraction, fermentation, and synthesis. JAKA Biotech focuses on providing high-quality active ingredients that enhance skin beauty, utilizing advanced technology to create innovative raw materials for cosmetic production. Through its commitment to quality and efficacy, JAKA Biotech aims to meet the demands of clients in the cosmetic industry.

CNE invests in order to develop the sectors operational productivity, has developed an advanced integrated support service platform separately, and provides employment of automatic process sorting devices to attain an intelligent, efficient, and service company process. CNE has handled tens of thousands of cross-border e-commerce sellers and is the largest provider of inter-e-commerce logistics operations.

GiantMed Diagnostics is a third-party medical laboratory that specializes in screening for complex eye diseases, particularly focusing on precision ophthalmology. The company offers comprehensive testing services for conditions such as uveitis and retinal choroidal diseases, among other ocular fundus diseases. By adhering to a patient-centered approach, GiantMed Diagnostics provides clinicians and patients with a one-stop solution that includes etiological testing, medical advice, consultations, and opportunities for scientific research collaboration. This integrated service model ensures high-quality testing and support for those affected by unexplained eye conditions.

SaintSages is a minimally invasive energy device enterprise. The company is headquartered in Shanghai, China.

Viewtrix Technology specializes in the development of display driver chips and circuit boards, focusing on enhancing display resolution and color representation across various types of screens, including OLED, LCD, and LED. The company’s technologies are designed to support a range of electronic devices such as mobile phones, tablets, and notebooks. By providing advanced display solutions, Viewtrix Technology enables electronics manufacturers to improve the quality of their products while simultaneously reducing costs.

Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

BSPK, Inc. is a digital platform designed specifically for luxury brands to enhance the client experience and drive sales. Founded in March 2017 and based in Menlo Park, California, BSPK enables sales advisers to engage with customers through various channels, including websites, in-store interactions, mobile applications, and video streaming. The platform provides sales associates with access to product images and sales data, allowing them to create personalized shopping experiences that foster stronger connections with high-net-worth clients. By empowering luxury brands to manage client data effectively, BSPK aims to improve client retention and ultimately increase sales.

BSPK, Inc. is a digital platform designed specifically for luxury brands to enhance the client experience and drive sales. Founded in March 2017 and based in Menlo Park, California, BSPK enables sales advisers to engage with customers through various channels, including websites, in-store interactions, mobile applications, and video streaming. The platform provides sales associates with access to product images and sales data, allowing them to create personalized shopping experiences that foster stronger connections with high-net-worth clients. By empowering luxury brands to manage client data effectively, BSPK aims to improve client retention and ultimately increase sales.

Kasa Korea Co., Ltd. is a company based in Seoul, South Korea, that specializes in developing a digital securities blockchain platform tailored for the real estate market. Established in 2018, Kasa's platform enables users to buy and trade securitized commercial real estate assets as asset-backed securities. By leveraging blockchain technology, the company aims to provide retail investors with a transparent and streamlined process for investing in real estate, facilitating the buying and selling of securitized assets in a more efficient manner.

Tensor Security is a full-stack endogenous cloud-native security solution. Their solution includes automation and devsecops,safety compliance, market container security,dynamic privileged account management, and cloud host security. Their cloud-native security platform builds a trusted image security system to ensure image security throughout the entire life cycle of cloud-native applications.

Hugo Biotech is a developer of high-throughput microbial sequencing technology, specializing in the analysis of microbial genomes and associated big data. The company has sequenced nearly 20,000 clinical samples for over 300 leading hospitals in China. Its innovative approach allows for the rapid and precise detection of pathogenic microorganisms in clinical samples, bypassing traditional culturing processes and specific amplification methods. This technology enhances the efficiency of microbial identification in healthcare settings, contributing to improved patient outcomes through timely diagnosis and treatment.

BrosMed is a company that specializes in interventional vascular therapy services and the development of medical devices aimed at enhancing procedural outcomes for healthcare professionals. The company's product offerings include a series of interventional cardiovascular and endovascular catheters, which are utilized by cardiologists, radiologists, and vascular surgeons during angioplasty procedures and other minimally invasive interventions. By providing advanced medical devices, BrosMed enables clinicians to expand treatment options available to patients, ultimately contributing to improved patient outcomes while also reducing costs.

Reworld is a platform offering training and IT tools that allow users to design their own videogames.

MemVerge is a technology company that specializes in Memory-Converged Infrastructure (MCI), utilizing its proprietary Distributed Memory Objects (DMO) technology. This innovative approach eliminates the traditional boundaries between memory and storage, allowing data-centric workloads to operate at memory speed. By leveraging Intel's Optane DC persistent memory, MemVerge enables seamless execution of data-intensive applications, including artificial intelligence, machine learning, big data analytics, IoT, and data warehousing. The company’s software ensures data consistency across multiple systems, empowering enterprises to efficiently process and gain insights from both small and large files.

TenaFe, Inc. is a technology company based in Campbell, California, that specializes in the development of solid-state drive (SSD) controllers. Founded in 2018, TenaFe focuses on creating innovative solutions for data storage challenges across various applications, including client devices, data centers, and emerging edge technologies. The company's patented technology aims to enhance the reliability, performance, and energy efficiency of SSDs, catering to a diverse range of devices from personal computers to connected gadgets. By leveraging its advanced controller technology, TenaFe seeks to provide clients with improved storage solutions that meet the evolving demands of modern data management.